Eli Lilly Financial Overview and Analysis

A detailed summary of Eli Lilly's (LLY) financial metrics, industry presence, and analysis of its fiscal year 2023 performance.

Aurora: Hello. Would you like to create a new portfolio?

User: What industries is LLY in? What is its market cap, revenue, net income, and free cash flow?

Aurora: Here is a summary of the financial and industry data for Eli Lilly and Company (symbol: LLY): ### Company Overview - **Name**: Eli Lilly and Company - **Ticker**: [LLY](https://nexustrade.io/stock/LLY) - **Exchange**: NYSE - **IPO Date**: June 1, 1972 ### Industries Eli Lilly operates in several industries, including: - Biotechnology - Healthcare - Immunotherapy - Medicine - Oncology - Pharmaceuticals - Research - Logistics and Supply Chain - Manufacturing - Digital Health - Bioinformatics - Computational Biology - Computational Chemistry - Chemicals - Distribution ### Financial Metrics - **Market Cap**: $878,725,657,308 (as of September 25, 2024) - **Revenue**: $11,302,800,000 - **Net Income**: $2,967,000,000 - **Free Cash Flow**: $63,255,141 - **Earnings Date**: August 9, 2024 ### Observations - Eli Lilly is a major player in the pharmaceutical and healthcare industries, with a strong focus on biotechnology and research. - The company has a substantial market capitalization, indicating its significant presence in the market. - The revenue and net income figures suggest a profitable operation, although the free cash flow is relatively modest compared to the net income. Please rem…

User: Analyze LLY's 2024 full year earnings

Aurora: It seems that I had to use fallback data for Eli Lilly's (LLY) financial analysis, specifically using the fiscal year 2023 data instead of the 2024 data. Therefore, I cannot provide a comparison between the two periods, but I can give you a detailed summary of the 2023 financial data that I retrieved. ### Financial Summary for Eli Lilly (FY 2023) 1. **Revenue and Income**: - **Revenue**: $34.124 billion - **Net Income**: $5.240 billion - **Gross Profit**: $27.041 billion - **Operating Income**: $10.325 billion 2. **Cash Flow**: - **Free Cash Flow**: -$3.148 billion - **Operating Cash Flow**: Calculated as $5.240 billion (Net Income) + $1.527 billion (Depreciation & Amortization) - $3.055 billion (Change in Working Capital) = $3.712 billion 3. **Profitability Metrics**: - **Gross Profit Margin**: 79.25% - **Operating Margin**: 30.26% - **Net Profit Margin**: 15.36% - **Return on Equity**: 48.24% - **Return on Assets**: 8.19% - **Return on Invested Capital**: 29.15% 4. **Liquidity and Solvency**: - **Current Ratio**: 0.94 (indicating potential liquidity concerns as it is below 1) - **Total Debt**: $25.225 billion - **Liabilities to Equity Ratio**: 4.89 (indicating high leverage) 5.…